|

Camrelizumab+Apatinib+Chemotherapy→Camrelizumab+Apatinib Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • The First Affiliated Hospital of Zhengzhou University1

Indications

  • Esophageal Cancer by AJCC V8 Stage1
  • Cancer1

Other1 trial

Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.